Since these immunosuppressive drugs were used by most of the patients in our cohort, this could be an explanation for the decline in ACPA levels after kidney transplantation and subsequent EBV infection, which we observed in a patient diagnosed with IgA nephropathy. This evidence concerns the gene PRTN3 and Epstein-Barr virus infection.